17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Potentially functional polymorphisms in the LIN28B gene contribute to neuroblastoma susceptibility in Chinese children

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Neuroblastoma is the most commonly diagnosed solid tumour outside the central nervous system in children. However, genetic factors underlying neuroblastoma remain largely unclear. Previous genome‐wide association study indicated that lin‐28 homolog B ( LIN28B) might play an important role in the development of neuroblastoma and also contributed to its poor overall survival. With the purpose to evaluate the association between LIN28B gene polymorphisms and neuroblastoma susceptibility in Southern Chinese population, we conducted this study with 256 neuroblastoma cases and 531 cancer‐free controls. Four potentially functional polymorphisms (rs221634 A>T, rs221635 T>C, rs314276 C>A and rs9404590 T>G) were genotyped using Taqman method. Odds ratios ( ORs) and 95% confidence intervals ( CIs) were calculated to assess the associations between the selected single nucleotide polymorphisms ( SNPs) and neuroblastoma susceptibility. We also performed genotype‐phenotype association analysis to explore the effects of the selected SNPs on LIN28B gene transcripts. Our results indicated that the rs221634 TT genotype was associated with an increased neuroblastoma risk ( TT versus AA/ AT: adjusted OR = 1.50, 95% CI = 1.04–2.17). The association was more pronounced in males, patients with tumour of mediastinum origin, as well as patients in early clinical stages. Moreover, overall analysis and stratified analysis also showed an increased risk of neuroblastoma for carrier of the 2–4 risk genotypes. In summary, these results indicated that the LIN28B rs221634 A>T polymorphism was associated with an increased neuroblastoma risk in Southern Chinese children. These findings need further validation in large studies with different ethnicities involved.

          Related collections

          Most cited references40

          • Record: found
          • Abstract: not found
          • Article: not found

          Recent advances in neuroblastoma.

          John Maris (2010)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Epidemiology of childhood cancer.

            The present contribution reports childhood cancer incidence and survival rates as well as time trends and geographical variation. The report is based on the databases of population-based cancer registries which joined forces in cooperative projects such as Automated Childhood Cancer Information System (ACCIS) and EUROCARE. According to these data, which refer to the International Classification of Childhood Cancer, leukemias, at 34%, brain tumors, at 23%, and lymphomas, at 12%, represent the largest diagnostic groups among the under 15-year-olds. The most frequent single diagnoses are: acute lymphoblastic leukemia, astrocytoma, neuroblastoma, non-Hodgkin lymphoma, and nephroblastoma. There is considerable variation between countries. Incidence rates range from 130 (British Isles) to 160 cases (Scandinavian countries) per million children. Incidence rates have shown an increase over time since the mid of the last century. In Europe, the yearly increase averages 1.1% for the 1978-1997 period and ranges from 0.6% for the leukemias to 1.8% for soft-tissue sarcomas. The probability of survival has risen considerably over the past decades, with the EUROCARE data showing an improvement of the relative risk of death by 8% when comparing the 2000-2002 time span to the 1995-1999 period. Regarding the years 1995-2002, the data show an overall 5-year survival probability of 81% for Europe and similar values for the USA. The data presented here describe the cancer situation with a specific, European focus. They are drawn from population-based cancer registries that ensure excellent data quality, and as a consequence represent the most valid European population-based data existing at present. It is also apparent that not all countries have data available from nationwide childhood cancer registries, a situation which warrants further improvement. 2010 Elsevier Ltd. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

              Based on preliminary experience, there was a need for modifications and clarifications in the International Neuroblastoma Staging System (INSS) and International Neuroblastoma Response Criteria (INRC). In 1988, a proposal was made to establish an internationally accepted staging system for neuroblastoma, as well as consistent criteria for confirming the diagnosis and determining response to therapy (Brodeur GM, et al: J Clin Oncol 6:1874-1881, 1988). A meeting was held to review experience with the INSS and INRC and to revise or clarify the language and intent of the originally proposed criteria. Substantial changes included a redefinition of the midline, restrictions on age and bone marrow involvement for stage 4S, and the recommendation that meta-iodobenzylguanidine (MIBG) scanning be implemented for evaluating the extent of disease. Other modifications and clarifications of the INSS and INRC are presented. In addition, the criteria for the diagnosis of neuroblastoma were modified. Finally, proposals were made for the development of risk groups that incorporate both clinical and biologic features in the prediction of prognosis. The biologic features that were deemed important to evaluate prospectively included serum ferritin, neuron-specific enolase (NSE), and lactic dehydrogenase (LDH); tumor histology; tumor-cell DNA content; assessment of N-myc copy number; assessment of 1p deletion by cytogenetic or molecular methods; and TRK-A expression. Modifications of the INSS and INRC made at this conference are presented. In addition, proposals are made for future modifications in these criteria and for the development of International Neuroblastoma Risk Groups.
                Bookmark

                Author and article information

                Journal
                J Cell Mol Med
                J. Cell. Mol. Med
                10.1111/(ISSN)1582-4934
                JCMM
                Journal of Cellular and Molecular Medicine
                John Wiley and Sons Inc. (Hoboken )
                1582-1838
                1582-4934
                29 March 2016
                August 2016
                : 20
                : 8 ( doiID: 10.1111/jcmm.2016.20.issue-8 )
                : 1534-1541
                Affiliations
                [ 1 ] Department of Pediatric Surgery Guangzhou Women and Children's Medical CenterGuangzhou Medical University Guangzhou GuangdongChina
                [ 2 ] Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Department of Experimental ResearchCollaborative Innovation Center for Cancer Medicine Guangzhou GuangdongChina
                [ 3 ] Molecular Epidemiology Laboratory and Department of Laboratory MedicineHarbin Medical University Cancer Hospital Harbin HeilongjiangChina
                Author notes
                [*] [* ] Correspondence to: Huimin XIA.

                E‐mail: xia-huimin@ 123456foxmail.com

                Jing He and Tianyou Yang contributed equally to this work.

                Article
                JCMM12846
                10.1111/jcmm.12846
                4956938
                27021521
                a57d56ca-8e5d-4196-9354-a99d154ca5b5
                © 2016 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.

                This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 07 December 2015
                : 22 February 2016
                Page count
                Pages: 8
                Funding
                Funded by: State Clinical Key Specialty Construction Project
                Award ID: GJLCZD1301
                Funded by: Clinical Medicine Research and Transformation Center of Brain Injury in Premature Infant in Guangzhou
                Award ID: 520101‐2150092
                Funded by: China Postdoctoral Science Foundation
                Award ID: 2014T70836
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                jcmm12846
                August 2016
                Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.2 mode:remove_FC converted:22.07.2016

                Molecular medicine
                lin28b,polymorphism,neuroblastoma,genetic susceptibility
                Molecular medicine
                lin28b, polymorphism, neuroblastoma, genetic susceptibility

                Comments

                Comment on this article